Clinical Trial Update: New Nasal Applicator / New Formulation - User Study [Phase 2]

View source ↗

Summary

A Phase 2 user study evaluating a new nasal applicator and formulation for seasonal allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Snippet

Sponsor: AstraZeneca | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED